$XBI down 3% today and 5% since before last Friday’s jobs report.

» Is this a smid-cap biopharma buying opportunity? 🤔

Stock market sell-off, e.g., $NASDAQ, started late last week on weak jobs data
XBI/smid-cap biopharma were part of sell-off
But..
» Is this sell-off justified for smid-cap biopharma?
» Is this a buying opportunity for smid-cap biopharma?

💡 Lower economic/jobs data = more likely entering lowering interest rate cycle for Fed Reserve
Usually good news for XBI/smid-cap biopharma. 🚀
Investors get less yield on lower risk investments
So risk/reward on higher risk long-term investments like smid-cap biopharma are more attractive

» Are you buying biopharma now, with the recent pullback in XBI?